In a mouse model of diet-induced MASH, treatment with semaglutide resulted in histological improvements in steatosis, inflammation, and fibrosis in liver compared to baseline, which was associated with body weight loss, intermittent periods of reduced food intake, and improvements in relevant biomarkers
Some ingredients are studied in relation to appetite, glucose regulation, and incretin pathways, but evidence quality varies and context matters
At Boon Aesthetics, we believe that skin health goes beyond just surface treatments
A., Scott, W
Conclusion Artificial intelligence holds substantial promise in transforming SCD care through improved prediction, personalization, and equity-driven resource allocation